logo

For the Inventor, By the Inventor

Tarzo, Italy

Valentina Gandin

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Università Degli Studi Di Camerino, Universitá Degli Studi Di Padova, Other. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valentina Gandin. Retrieved from https://idiyas.com/inventor/valentina-gandin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Tarzo, IT (2015)
  • Padua, IT (2015)

Company Filing History:

goldMedal1 out of 4 
 
Università Degli Studi Di Camerino
 patents
silverMedal1 out of 43 
 
Universitá Degli Studi Di Padova
 patents
bronzeMedal1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2015

Loading Chart...
2 patents (USPTO):Explore Patents
1. 9220705 - Method of treating colorectal cancer (2015-12-29),
2. 9114149 - [CU(thp)4]n[X]-n compounds for the treatment of a broad range of human solid tumors, including refractory tumors (2015-08-25),

Title: Valentina Gandin: Innovator in Cancer Treatment

Introduction

Valentina Gandin is a prominent inventor based in Tarzo, Italy. She has made significant contributions to the field of cancer treatment, particularly in developing methods for addressing colorectal cancer. With a total of 2 patents, her work is recognized for its potential impact on medical science.

Latest Patents

One of Valentina Gandin's latest patents is a method of treating colorectal cancer. This invention relates to the use of certain platinum compounds, including [PtCl(cis-1,4-diaminocyclohexane], or combinations of these compounds with various agents for treating and preventing the progression of colorectal cancer in mammals. The invention specifically provides methods for treating and preventing oxaliplatin-refractory colorectal cancer. Another notable patent involves [Cu(thp)4]n[X]-n compounds for the treatment of a broad range of human solid tumors, including refractory tumors. These Cu(I) complexes are designed to serve as antineoplastic agents against solid tumors in humans.

Career Highlights

Valentina Gandin has worked with esteemed institutions such as the University of Padua and the University of Camerino. Her research and innovations have garnered attention in the scientific community, contributing to advancements in cancer therapies.

Collaborations

Valentina has collaborated with notable colleagues, including Cristina Marzano and Marina Porchia. These partnerships have played a crucial role in her research endeavors and the development of her patents.

Conclusion

Valentina Gandin's work exemplifies the innovative spirit in the field of cancer treatment. Her contributions through her patents highlight the importance of research in developing effective therapies for challenging medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…